NCT01288872View on ClinicalTrials.gov

Praziquantel-Pharmacokinetic Study

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Schistosomiasis
Interventions
DRUG

Praziquantel

Praziquantel (PZQ), 60 mg/kg, administered orally in split dose (30 mg/kg each dose) separated by three hours.

Trial Locations (1)

1781

Research Institute for Tropical Medicine - Health Compound, Muntinlupa City

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01288872 - Praziquantel-Pharmacokinetic Study | Biotech Hunter | Biotech Hunter